About Cold-EEZE
Cold-EEZE was founded in 2000 and is headquartered in Morgantown, United States. Zinc-based medicinal lozenges and syrups are developed and distributed by the company to address symptoms of cough, cold, and allergies. Operations are centered in the over-the-counter pharmaceutical sector, with products aimed at consumer health needs across domestic markets.
- Headquarter Morgantown, United States
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cold-EEZE
Detailed funding history for Cold-EEZE
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cold-EEZE
Cold-EEZE has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Mylan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic and specialty pharmaceuticals are manufactured and marketed globally.
|
Locked | Locked | Locked |
Investor details for Cold-EEZE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cold-EEZE
Investment portfolio details for Cold-EEZE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cold-EEZE
Detailed financials for Cold-EEZE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cold-Eeze Comparisons
Peer comparison for Cold-EEZE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cold-EEZE
Detailed competitors of Cold-EEZE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cold-Eeze
Complete news archive for Cold-EEZE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cold-EEZE
Cold-EEZE was founded in 2000.
Cold-EEZE is headquartered in Morgantown, United States. It is registered at Morgantown, West Virginia, United States.
Cold-EEZE was founded in 2000 and is headquartered in Morgantown, United States. Zinc-based medicinal lozenges and syrups are developed and distributed by the company to address symptoms of cough, cold, and allergies. Operations are centered in the over-the-counter pharmaceutical sector, with products aimed at consumer health needs across domestic markets.
Cold-EEZE has 1 investor. Key investors include Mylan.